Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy

Seminars in Liver Disease

Volumn 28, Issue 3, 2008, Pages 315-327

  Perarnau, Jean Marc ^a   Bacq, Yannick ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Budd Chiari syndrome; Estrogen; HELLP syndrome; Portal hypertension; Portal thrombosis; Preeclampsia; Pregnancy

Indexed keywords

ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONJUGATED ESTROGEN; CORTICOSTEROID; DESOGESTREL; DROSPIRENONE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; GADOLINIUM; GESTAGEN; HEPARIN; LEVONORGESTREL; LOW MOLECULAR WEIGHT HEPARIN; NORETHISTERONE; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; PREGNANE DERIVATIVE; PROGESTERONE; RALOXIFENE; TAMOXIFEN; WARFARIN;

AMNIONITIS; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD CLOTTING; BRADYCARDIA; BUDD CHIARI SYNDROME; CONGENITAL DISORDER; DETERIORATION; DIALYSIS; DRUG HALF LIFE; DRUG SUBSTITUTION; DYSTOCIA; ESTROGEN THERAPY; HELLP SYNDROME; HEMATOMA; HEMODYNAMICS; HEMORRHAGIC SHOCK; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYSTERECTOMY; INTRAUTERINE GROWTH RETARDATION; LIVER DISEASE; LIVER FUNCTION TEST; LIVER HEMANGIOMA; LIVER SINUSOIDAL DILATATION; LIVER TRANSPLANTATION; LIVER VEIN OBSTRUCTION; LIVER VEIN THROMBOSIS; LIVER VENOOCCLUSIVE DISEASE; MENSTRUATION; NODULAR HYPERPLASIA; NONHUMAN; ORAL CONTRACEPTION; PELIOSIS HEPATIS; PORTAL HYPERTENSION; PORTAL VEIN OBSTRUCTION; PORTAL VEIN THROMBOSIS; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; SHUNTING; SIDE EFFECT; SPONTANEOUS ABORTION; THROMBOPHILIA; THROMBOSIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARIX BLEEDING; VENOUS THROMBOEMBOLISM;

BLOOD COAGULATION DISORDERS; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HELLP SYNDROME; HEMODYNAMICS; HUMANS; LIVER; LIVER CIRCULATION; LIVER DISEASES; PORTAL VEIN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; VASCULAR DISEASES; VENOUS THROMBOEMBOLISM;

EID: 52949087176     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0028-1085099     Document Type: Review

References (143)

1. Lund CJ, Donovan JC. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol 1967;98:394-403
2. Peck TM, Arias F. Hematologic changes associated with pregnancy. Clin Obstet Gynecol 1979;22:785-798
3. Rovinsky JJ, Jaffin H. Cardiovascular hemodynamics in pregnancy. 3. Cardiac rate, stroke volume, total peripheral resistance, and central blood volume in multiple pregnancy. Synthesis of results. Am J Obstet Gynecol 1966;95:787-794
4. Laakso L, Ruotsalainen P, Punnonen R, Maatela J. Hepatic blood flow during late pregnancy. Acta Obstet Gynecol Scand 1971;50:175-178
5. Munnell EW, Taylor HC. Liver blood flow in pregnancyhepatic vein catheterization. J Clin Invest 1947;26:952-956
6. Clapp JF III, Stepanchak W, Tomaselli J, Kortan M, Faneslow S. Portal vein blood flow-effects of pregnancy, gravity, and exercise. Am J Obstet Gynecol 2000;183:167-172
7. Mayo MA, Lopez-Cano A, Mendez C, et al. Hemodynamic modifications in splenic circulation studied by echo-Doppler during pregnancy. Gastroenterol Hepatol 2002;25: 148-152
8. James AH. Prevention and management of venous thromboembolism in pregnancy. Am J Med 2007;120:S26-S34
9. Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005;143:697-706
10. Lim W, Eikelboom JW, Ginsberg JS. Inherited thrombophilia and pregnancy associated venous thromboembolism. BMJ 2007;334:1318-1321
11. Battaglioli T, Martinelli I. Hormone therapy and thromboembolic disease. Curr Opin Hematol 2007;14:488-493
12. Rosing J, Middeldorp S, Curvers J, et al. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Lancet 1999;354:2036-2040
13. Cole JA, Norman H, Doherty M, Walker AM. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 2007;109:339-346
14. Wu O, Robertson L, Langhorne P, et al. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thromb Haemost 2005; 94:17-25
15. Wu O, Robertson L, Twaddle S, et al. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol 2005;131: 80-90
16. Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmeno-pausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007;115:840-845
17. Toorians AW, Thomassen MC, Zweegman S, et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab 2003;88:5723-5729
18. Miller AP, Chen YF, Xing D, Feng W, Oparil S. Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Hypertension 2003;42:657-663
19. Sgarabotto M, Baldini M, Dei Cas A, et al. Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study. Thromb Res 2007;119:85-91
20. Kluft C. Effects of hormone treatment on hemostasis variables. Climacteric 2007;10(Suppl 2):32-37
21. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. J Hepatol 2005;43:167-176
22. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44:1308-1316
23. Rautou PE, Angermayr B, Raffa S, et al. Maternal and fetal outcome in 27 women with Budd-Chiari syndrome (BCS) and 41 pregnancies. Hepatology 2007;46:563 (abstract)
24. Marks PW. Management of thromboembolism in pregnancy. Semin Perinatol 2007;31:227-231
25. Khuroo MS, Datta DV. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med 1980;68:113-121
26. Singh V, Sinha SK, Nain CK, et al. Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol 2000; 15:550-554
27. Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994;73:21-36
28. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology 2001; 34:666-670
29. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587-591
30. Webb JA, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005;15:1234-1240
31. Lin SP, Brown JJ. MR contrast agents: physical and pharmacologic basics. J Magn Reson Imaging 2007;25: 884-899
32. Joffe GM, Aisenbrey GA, Argubright KF. Budd-Chiari syndrome, systemic lupus erythematosus, and secondary antiphospholipid antibody syndrome in pregnancy. Obstet Gynecol 2005;106:1191-1194
33. Wildberger JE, Vorwerk D, Winograd R, et al. New TIPS placement in pregnancy in recurrent esophageal varices hemorrhage-assessment of fetal radiation exposure. Rofo 1998;169:429-431
34. Savage C, Patel J, Lepe MR, Lazarre CH, Rees CR. Transjugular intrahepatic portosystemic shunt creation for recurrent gastrointestinal bleeding during pregnancy. J Vasc Interv Radiol 2007;18:902-904
35. Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis 2002;22:5-14
36. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96:2364-2368
37. Pajor A, Lehoczky D. Pregnancy and extrahepatic portal hypertension. Review and report on the management. Gynecol Obstet Invest 1990;30:193-197
38. Cheng YS. Pregnancy in liver cirrhosis and/or portal hypertension. Am J Obstet Gynecol 1977;128:812-822
39. Kochhar R, Kumar S, Goel RC, et al. Pregnancy and its outcome in patients with noncirrhotic portal hypertension. Dig Dis Sci 1999;44:1356-1361
40. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46:922-938
41. Mahadevan U, Kane S. American Gastroenterological Association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006;131:283-311
42. Starkel P, Horsmans Y, Geubel A. Endoscopic band ligation: a safe technique to control bleeding esophageal varices in pregnancy. Gastrointest Endosc 1998;48:212-214
43. Hay JE. Liver disease in pregnancy. Hepatology 2008;47: 1067-1076
44. Aggarwal N, Sawhney H, Vasishta K, Dhiman RK, Chawla Y. Non-cirrhotic portal hypertension in pregnancy. Int J Gynaecol Obstet 2001;72:1-7
45. Britton RC. Pregnancy and esophageal varices. Am J Surg 1982;143:421-425
46. Restaino A, Campobasso C, D'Aloya A, et al. Cirrhosis and pregnancy. A case report and review of the literature. Clin Exp Obstet Gynecol 1996;23:240-247
47. Heriot JA, Steven CM, Sattin RS. Elective forceps delivery and extradural anaesthesia in a primigravida with portal hypertension and oesophageal varices. Br J Anaesth 1996; 76:325-327
48. Sarin SK, Sollano JD, Chawla YK, et al. Consensus on extra-hepatic portal vein obstruction. Liver Int 2006;26: 512-519
49. Goodrich MA, James EM, Baldus WP, Lomboy CT, Harms RW. Portal vein thrombosis associated with pregnancy. A case report. J Reprod Med 1993;38:969-972
50. Janssen HL, Wijnhoud A, Haagsma EB, et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001;49:720-724
51. Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005;41:603-608
52. Yapar EG, Bilge U, Dumanli H, Vural T, Gokmen O. Portal vein thrombosis concomitant with thrombophilia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;68:213-217
53. Bianconcini G, Parolari G, Gobbi F, Zinelli G. Pregnancy complication in homozygous (delta beta) zero-thalassemia. A clinical case. Minerva Med 1993;84:203-209
54. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000;32:466-470
55. Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000;32:865-871
56. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002;22:27-42
57. Hagglund H, Remberger M, Klaesson S, et al. Norethister-one treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. Blood 1998;92:4568-4572
58. Hillaire S, Bonte E, Denninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002;51:275-280
59. Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol 2007;46:499-507
60. Shovlin CL, Winstock AR, Peters AM, Jackson JE, Hughes JM. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. QJM 1995;88:879-887
61. Livneh A, Langevitz P, Morag B, Catania A, Pras M. Functionally reversible hepatic arteriovenous fistulas during pregnancy in patients with hereditary hemorrhagic telan-giectasia. South Med J 1988;81:1047-1049
62. Hillert C, Broering DC, Gundlach M, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: an unusual indication for liver transplantation. Liver Transpl 2001;7:266-268
63. McInroy B, Zajko AB, Pinna AD. Biliary necrosis due to hepatic involvement with hereditary hemorrhagic telangiectasia. AJR Am J Roentgenol 1998;170:413-415
64. Reddy KR, Kligerman S, Levi J, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001;67:173-178
65. Saegusa T, Ito K, Oba N, et al. Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med 1995;34:207-211
66. Gungor T, Aytan H, Tapisiz OL, Zergeroglu S. An unusual case of incidental rupture of liver hemangioma during labor. Chin Med J (Engl) 2004;117:311-313
67. Krasuski P, Poniecka A, Gal E, Wali A. Intrapartum spontaneous rupture of liver hemangioma. J Matern Fetal Med 2001;10:290-292
68. Fouchard I, Rosenau L, Cales P, Allory P. Survenue d'hémangiomes hépatiques au cours de la grossesse. Gastroenterol Clin Biol 1994;18:512-515
69. Reyes M, Monsalve V, Hepp J, Vaccaro H. A giant hepatic hemangioma and pregnancy. Rev Chil Obstet Ginecol 1992;57:359-361
70. Graham E, Cohen AW, Soulen M, Faye R. Symptomatic liver hemangioma with intra-tumor hemorrhage treated by angiography and embolization during pregnancy. Obstet Gynecol 1993;81:813-816
71. Glinkova V, Shevah O, Boaz M, Levine A, Shirin H. Hepatic haemangiomas: possible association with female sex hormones. Gut 2004;53:1352-1355
72. Gemer O, Moscovici O, Ben-Horin CL, et al. Oral contraceptives and liver hemangioma: a case-control study. Acta Obstet Gynecol Scand 2004;83:1199-1201
73. Ozakyol A, Kebapci M. Enhanced growth of hepatic hemangiomatosis in two adults after postmenopausal estrogen replacement therapy. Tohoku J Exp Med 2006;210: 257-261
74. Lui W, Zhang S, Hu T, et al. Sex hormone receptors of hemangiomas in children. Chin Med J (Engl) 1997;110: 349-351
75. Xiao X, Hong L, Sheng M. Promoting effect of estrogen on the proliferation of hemangioma vascular endothelial cells in vitro. J Pediatr Surg 1999;34:1603-1605
76. Xiao X, Liu J, Sheng M. Synergistic effect of estrogen and VEGF on the proliferation of hemangioma vascular endothelial cells. J Pediatr Surg 2004;39:1107-1110
77. Wanless IR. Vasular disorders. In: MacSween RNM, Burt AD, Portman BC, Ishak KG, Scheuer PJ, Anthony PP, eds. Pathology of the Liver. 4th ed. Glasgow, UK: Churchill Livingstone; 2002:540-573
78. Cobey FC, Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004;187:181-191
79. Scott LD, Katz AR, Duke JH, Cowan DF, Maklad NF. Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. JAMA 1984;251:1461-1463
80. Heinemann LA, Weimann A, Gerken G, et al. Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. Eur J Contracept Reprod Health Care 1998;3:194-200
81. Scalori A, Tavani A, Gallus S, La Vecchia C, Colombo M. Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. Am J Obstet Gynecol 2002;186:195-197
82. Mathieu D, Kobeiter H, Maison P, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000;118:560-564
83. Spellberg MA, Mirro J, Chowdhury L. Hepatic sinusoidal dilatation related to oral contraceptives. A study of two patients showing ultrastructural changes. Am J Gastroenterol 1979;72:248-252
84. Winkler K, Poulsen H. Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids. Scand J Gastroenterol 1975;10:699-704
85. Balazs M. Sinusoidal dilatation of the liver in patients on oral contraceptives. Electron microscopical study of 14 cases. Exp Pathol 1988;35:231-237
86. Camilleri M, Schafler K, Chadwick VS, Hodgson HJ, Weinbren K. Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology 1981;80:810-815
87. Raufman JP, Miller DL, Gumucio JJ. Estrogen-induced zonal changes in rat liver sinusoids. Gastroenterology 1980; 79:1174-1177
88. Oligny LL, Lough J. Hepatic sinusoidal ectasia. Hum Pathol 1992;23:953-956
89. Weinberger M, Garty M, Cohen M, Russo Y, Rosenfeld JB. Ultrasonography in the diagnosis and follow-up of hepatic sinusoidal dilatation. Arch Intern Med 1985;145: 927-929
90. Fisher MR, Neiman HL. Periportal sinusoidal dilatation associated with pregnancy. Cardiovasc Intervent Radiol 1984;7:299-302
91. Yang DM, Jung DH, Park CH, Kim JE, Choi SJ. Imaging findings of hepatic sinusoidal dilatation. AJR Am J Roentgenol 2004;183:1075-1077
92. Iannaccone R, Federle MP, Brancatelli G, et al. Peliosis hepatis: spectrum of imaging findings. AJR Am J Roentgenol 2006;187:W43-52
93. van Erpecum KJ, Janssens AR, Kreuning J, et al. Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives. Am J Gastroenterol 1988;83:572-575
94. Patricot LM, Dumont M, Duvernois JP, Baulieux J, Mercatello A. A case of hepatic and splenic peliosis occurring in the puerperium after normal pregnancy. J Gynecol Obstet Biol Reprod (Paris) 1986;15:321-326
95. Barron WM. The syndrome of preeclampsia. Gastroenterol Clin North Am 1992;21:851-872
96. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799
97. Serrano NC. Immunology and genetic of preeclampsia. Clin Dev Immunol 2006;13:197-201
98. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol 2007;2:543-549
99. Sibai BM, Hauth J, Caritis S, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000;182:938-942
100. Malone FD, Kaufman GE, Chelmow D, et al. Maternal morbidity associated with triplet pregnancy. Am J Perinatol 1998;15:73-77
101. Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-1006
102. Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001;344:867-872
103. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902-905
104. Ward K, Hata A, Jeunemaitre X, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993;4:59-61
105. Rajkovic A, Catalano PM, Malinow MR. Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol 1997;90:168-171
106. Clausen T, Slott M, Solvoll K, et al. High intake of energy, sucrose, and polyunsaturated fatty acids is associated with increased risk of preeclampsia. Am J Obstet Gynecol 2001; 185:451-458
107. Solomon CG, Seely EW. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension 2001;37:232-239
108. Chambers JC, Fusi L, Malik IS, et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001;285:1607-1612
109. Hulstein JJ, van Runnard Heimel PJ, Franx A, et al. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. J Thromb Haemost 2006;4:2569-2575
110. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999;354:810-816
111. Redman CW, Sargent IL. The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil 2001;29:518-522
112. Stella CL, Sibai BM. Preeclampsia: diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med 2006;19:381-386
113. Rolfes DB, Ishak KG. Liver disease in toxemia of pregnancy. Am J Gastroenterol 1986;81:1138-1144
114. Riely CA. The liver in preeclampsia/eclampsia: the tip of the iceberg. Am J Gastroenterol 1986;81:1218-1219
115. Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002;51:876-880
116. Arias F, Mancilla-Jimenez R. Hepatic fibrinogen deposits in pre-eclampsia. Immunofluorescent evidence. N Engl J Med 1976;295:578-582
117. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:159-167
118. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195:914-934
119. Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460-464
120. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995;172:125-129
121. Barton JR, Riely CA, Adamec TA, et al. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1992;167:1538-1543
122. Barton JR, Sibai BM. Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1996;174:1820-1825; discussion 1825-1827
123. Nunes JO, Turner MA, Fulcher AS. Abdominal imaging features of HELLP syndrome: a 10-year retrospective review. AJR Am J Roentgenol 2005;185:1205-1210
124. Bacq Y. Acute fatty liver of pregnancy. Semin Perinatol 1998;22:134-140
125. Sibai BM. Imitators of severe preeclampsia. Obstet Gynecol 2007;109:956-966
126. Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999;340:1723-1731
127. Ibdah JA. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006;12:7397-7404
128. den Boer ME, Ijlst L, Wijburg FA, et al. Heterozygosity for the common LCHAD mutation (1528g>C) is not a major cause of HELLP syndrome and the prevalence of the mutation in the Dutch population is low. Pediatr Res 2000;48:151-154
129. Mutze S, Ahillen I, Rudnik-Schoeneborn S, et al. Neither maternal nor fetal mutation (E474Q) in the alpha-subunit of the trifunctional protein is frequent in pregnancies complicated by HELLP syndrome. J Perinat Med 2007; 35:76-78
130. Isler CM, Rinehart BK, Terrone DA, et al. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999;181:924-928
131. Catanzarite VA, Steinberg SM, Mosley CA, et al. Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death. Am J Perinatol 1995;12:310-313
132. Shames BD, Fernandez LA, Sollinger HW, et al. Liver transplantation for HELLP syndrome. Liver Transpl 2005; 11:224-228
133. Zarrinpar A, Farmer DG, Ghobrial RM, et al. Liver transplantation for HELLP syndrome. Am Surg 2007;73: 1013-1016
134. Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004;31:807-833; vii
135. van Runnard Heimel PJ, Franx A, Schobben AF, et al. Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv 2005;60:57-70; quiz 73-54
136. Krueger KJ, Hoffman BJ, Lee WM. Hepatic infarction associated with eclampsia. Am J Gastroenterol 1990;85: 588-592
137. Schwartz ML, Lien JM. Spontaneous liver hematoma in pregnancy not clearly associated with preeclampsia: a case presentation and literature review. Am J Obstet Gynecol 1997;176:1328-1332; discussion 1332-1323
138. Stevenson JT, Graham DJ. Hepatic hemorrhage and the HELLP syndrome: a surgeon's perspective. Am Surg 1995; 61:756-760
139. Erhard J, Lange R, Niebel W, et al. Acute liver necrosis in the HELLP syndrome: successful outcome after orthotopic liver transplantation. A case report. Transpl Int 1993;6: 179-181
140. Hunter SK, Martin M, Benda JA, Zlatnik FJ. Liver transplant after massive spontaneous hepatic rupture in pregnancy complicated by preeclampsia. Obstet Gynecol 1995;85:819-822
141. Strate T, Broering DC, Bloechle C, et al. Orthotopic liver transplantation for complicated HELLP syndrome. Case report and review of the literature. Arch Gynecol Obstet 2000;264:108-111
142. Greenstein D, Henderson JM, Boyer TD. Liver hemorrhage: recurrent episodes during pregnancy complicated by preeclampsia. Gastroenterology 1994;106:1668-1671
143. Ishak KG. Hepatic lesions caused by anabolic and contraceptive steroids. Semin Liver Dis 1981;1:116-128